Europese Unie - Nederlands - EMA (European Medicines Agency)

samsung bioepis nl b.v. - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - ophthalmologica - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

Europese Unie - Nederlands - EMA (European Medicines Agency)

midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - ophthalmologica - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).

Europese Unie - Nederlands - EMA (European Medicines Agency)

stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - ophthalmologica - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

medgenix benelux sa-nv - folcodine 1 mg/ml; sulfoguaiacol 20 mg/ml - siroop - 15 mg/15 ml,300 mg/15 ml - folcodine 1 mg/ml; sulfoguaiacol 20 mg/ml - pholcodine

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

omedicamed unipessoal lda - bacterienlysaat 3,5 mg - capsule, hard - 3,5 mg - diplococcus pneumoniae; haemophilus influenzae; klebsiella ozaenae; klebsiella pneumoniae; neisseria catarrhalis; streptococcus pyogenes; streptococcus viridans; geïnactiveerd staphylococcus aureus - other bacterial vaccines

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

omedicamed unipessoal lda - bacterienlysaat 7 mg - capsule, hard - 7 mg - diplococcus pneumoniae; haemophilus influenzae; neisseria catarrhalis; klebsiella ozaenae; klebsiella pneumoniae; streptococcus viridans; geïnactiveerd staphylococcus aureus; streptococcus pyogenes - other bacterial vaccines

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pi pharma sa-nv - bacterienlysaat 3,5 mg - capsule, hard - other bacterial vaccines

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pi pharma sa-nv - bacterienlysaat 7 mg - capsule, hard - other bacterial vaccines

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pi pharma sa-nv - bacterienlysaat 7 mg - capsule, hard - other bacterial vaccines

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

orifarm a.s. - bacterienlysaat - capsule, hard - other bacterial vaccines